23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › BioLife Solutions, Inc. › 2025-2026

BioLife Solutions, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BioLife Solutions, Inc.’s Form 8-K, filed August 21, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 9Ballot items
  • 261Asset managers, any item
  • 2,512Fund votes
  • August 20, 2025Meeting date

Results at a glance

Meeting of August 20, 2025: 9 items on BioLife Solutions, Inc.’s Form 8-K, filed August 21, 2025: 6 elected · 2 approved · 1 passed (calculated).

Dissent

Significant dissent: 2 directors (48.9%, 43.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BioLife Solutions, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by BioLife Solutions, Inc.

These tallies are BioLife Solutions, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 21, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BioLife Solutions, Inc. — official shareholder meeting results, meeting held August 20, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Roderick de Greef 39,608,298---- 940,3902,514,349 98%Passed (calculated)—
Elect Director: Catherine Coste 40,460,424---- 88,2642,514,349 99.8%Elected—
Elect Director: Amy DuRoss 39,902,654---- 646,0342,514,349 98%Elected—
Elect Director: Rachel Ellingson 20,731,406---- 19,817,2822,514,349 51.1%Elected—
Elect Director: Joydeep Goswami 23,021,878---- 17,526,8102,514,349 57%Elected—
Elect Director: Tony Hunt 39,264,968---- 1,283,7202,514,349 97%Elected—
Elect Director: Timothy Moore 40,089,287---- 459,4012,514,349 99%Elected—
2. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers 38,403,8562,060,35284,480 --2,514,349 95%Approved—
3. Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 43,024,01911,16927,849 ---- 99.9%Approved—

Source: BioLife Solutions, Inc., Form 8-K, filed with the SEC on August 21, 2025 — read the filing on EDGAR.

How asset managers voted at the BioLife Solutions, Inc. 2025-2026 meeting

261 asset managers disclosed a vote on at least one BioLife Solutions, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Amy DuRoss

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 39,902,654WITHHELD: 646,034

Prior year: 96.7% for (August 1, 2024 meeting) ▲ 1.8 pts

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Amy DuRoss

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Amy DuRoss”): 39,902,654 for, 646,034 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,503,393 for, 30,991 withheld, 1,219 abstained.

FOR
FOR: 20,503,393ABSTAIN: 1,219WITHHOLD: 30,991
Largest asset managers voting on “Election of Directors: Amy DuRoss” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,758,8950 15,915For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,2030 0694For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Catherine Coste

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 40,460,424WITHHELD: 88,264
Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Cathy Coste

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Catherine Coste”): 40,460,424 for, 88,264 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,535,603 for.

FOR
FOR: 20,535,603
Largest asset managers voting on “Election of Directors: Cathy Coste” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8120 00For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Joydeep Goswami

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

57% Majority: yes · of votes cast

FOR 57%WITHHELD
FOR: 23,021,878WITHHELD: 17,526,810

Prior year: 63.4% for (August 1, 2024 meeting) ▼ 6.6 pts

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Joydeep Goswami

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Joydeep Goswami”): 23,021,878 for, 17,526,810 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 57% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 11,274,353 for, 9,081,312 withheld, 179,938 abstained.

FORWITHHOLD
FOR: 11,274,353ABSTAIN: 179,938WITHHOLD: 9,081,312
Largest asset managers voting on “Election of Directors: Joydeep Goswami” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price00 03,023,800Withhold
Vanguard2,758,8700 265,915For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS00 01,176,523Withhold
Columbia Threadneedle00 01,067,406Withhold
MFS00 01,005,987Withhold
Fidelity800,7880 00For
Jackson National596,4300 162,4550Mixed
Royce587,2460 00For
State Street4970 0538,400Withhold
Voya00 0480,471Withhold
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide302,3790 03,496For
Brighthouse292,7120 012,209For
Charles Schwab299,8050 00For
MoA Funds Corp00 0283,422Withhold
Dimensional00 0254,580Withhold
Allspring00 0171,892Withhold
AIG/SunAmerica00 0124,196Withhold
Victory Capital00 0113,748Withhold
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life11,3850 096,143Mixed
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Rachel Ellingson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

51.1% Majority: yes · of votes cast

FOR 51.1%WITHHELD
FOR: 20,731,406WITHHELD: 19,817,282

Prior year: 61.1% for (August 1, 2024 meeting) ▼ 10.0 pts

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Rachel Ellingson

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Rachel Ellingson”): 20,731,406 for, 19,817,282 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 51.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 8,599,530 for, 11,159,918 withheld, 776,155 abstained.

FORWITHHOLD
FOR: 8,599,530ABSTAIN: 776,155WITHHOLD: 11,159,918
Largest asset managers voting on “Election of Directors: Rachel Ellingson” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price00 03,023,800Withhold
Vanguard2,760,9620 243,826For
BlackRock2,423,4940 00For
Invesco00 01,910,656Withhold
ALGER FUNDS00 01,176,523Withhold
Columbia Threadneedle00 01,067,406Withhold
MFS00 01,005,987Withhold
Fidelity800,7880 00For
Jackson National00 758,8850Abstain
Royce587,2460 00For
State Street4970 0538,400Withhold
Voya00 0480,471Withhold
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide302,3790 03,496For
Brighthouse00 0304,921Withhold
Charles Schwab299,8050 00For
MoA Funds Corp00 0283,422Withhold
Dimensional00 0254,580Withhold
Allspring00 0171,892Withhold
AIG/SunAmerica00 0124,196Withhold
Victory Capital00 0113,748Withhold
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life11,3850 096,143Mixed
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Timothy Moore

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 40,089,287WITHHELD: 459,401

Prior year: 97.9% for (August 1, 2024 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Timothy L. Moore

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Timothy Moore”): 40,089,287 for, 459,401 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,509,130 for, 26,472 withheld, 1 abstained.

FOR
FOR: 20,509,130ABSTAIN: 1WITHHOLD: 26,472
Largest asset managers voting on “Election of Directors: Timothy L. Moore” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,762,7210 12,090For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Tony Hunt

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 39,264,968WITHHELD: 1,283,720
Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Directors: Tony Hunt

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Tony Hunt”): 39,264,968 for, 1,283,720 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,052,407 for, 483,194 withheld, 2 abstained.

FOR
FOR: 20,052,407ABSTAIN: 2WITHHOLD: 483,194
Largest asset managers voting on “Election of Directors: Tony Hunt” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8100 20For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya00 0480,471Withhold
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide304,8990 0976For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).

Elect Director: Roderick de Greef

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 39,608,298WITHHELD: 940,390

Prior year: 99.0% for (August 1, 2024 meeting) ▼ 1.3 pts

Details: description as filed, official tally, votes by 71 asset managers

Description as filed by funds: Election of Directors: Roderick de Greef

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Roderick de Greef”): 39,608,298 for, 940,390 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 20,041,591 for, 483,920 withheld, 2 abstained.

FOR
FOR: 20,041,591ABSTAIN: 2WITHHOLD: 483,920
Largest asset managers voting on “Election of Directors: Roderick de Greef” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8100 20For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8800 017For
Voya00 0480,471Withhold
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).

Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 38,403,856AGAINST: 2,060,352

Prior year: 86.8% for (August 1, 2024 meeting) ▲ 8.1 pts

Details: description as filed, official tally, votes by 257 asset managers

Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

BioLife Solutions, Inc.’s own tally for this item (“2. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers”): 38,403,856 for, 2,060,352 against — passed, per its Form 8-K filed August 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers by a non-binding, advisory vote was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 74 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,762,7192,093 00For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS01,176,523 00Against
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,659238 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Fund voting reports, all 74 managers: 19,374,916 for, 1,182,286 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 207 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC6,875,4810 00For
T. Rowe Price4,407,9180 00For
Invesco2,994,1680 00For
FRED ALGER MANAGEMENT, LLC01,277,349 00Against
State Street1,195,006329 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,102,1300 00For
GEODE CAPITAL MANAGEMENT, LLC888,0790 00For
BlackRock820,1656,293 00For
GENEVA CAPITAL MANAGEMENT LLC727,3570 00For
Voya480,471225,752 00Mixed
PALISADE CAPITAL MANAGEMENT, LP560,4670 00For
Granahan Investment Management, LLC522,5750 00For
EAGLE ASSET MANAGEMENT INC485,4490 00For
ROCKEFELLER & CO. LLC433,0360 00For
CRAMER ROSENTHAL MCGLYNN LLC392,1340 00For
BANK OF AMERICA NA350,9500 00For
Charles Schwab343,2780 00For
Northern Trust332,5410 00For
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC297,7100 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM291,1840 00For
Allianz0261,916 00Against
Allspring255,5050 00For
MELLON INVESTMENTS Corp211,3860 00For
ENVESTNET ASSET MANAGEMENT INC207,5080 00For
Stephens Investment Management Group LLC193,3080 00For

Institutional-manager reports, all 207 managers: 27,532,569 for, 1,940,786 against, 152 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 43,024,019AGAINST: 11,169

Prior year: 99.9% for (August 1, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

BioLife Solutions, Inc.’s own tally for this item (“3. Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 43,024,019 for, 11,169 against — passed, per its Form 8-K filed August 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 20,557,202 for.

FOR
FOR: 20,557,202
Largest asset managers voting on “To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public ac” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8120 00For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Nationwide305,8750 00For
Brighthouse304,9210 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica124,1960 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Largest BioLife Solutions, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 46,104,888 shares outstanding at the time of that meeting.

Fund voting reports: top BioLife Solutions, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2025-2026
#Asset manager % of shares outstanding
1T. Rowe Price 6.56%
2Vanguard 6.00%
3BlackRock 5.26%
4Invesco 4.14%
5ALGER FUNDS 2.55%
6Columbia Threadneedle 2.32%
7MFS 2.18%
8Fidelity 1.74%
9Jackson National 1.65%
10Royce 1.27%
Institutional-manager reports: top BioLife Solutions, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2025-2026
#Asset manager % of shares outstanding
1Casdin Capital, LLC 14.91%
2T. Rowe Price 9.56%
3Invesco 6.49%
4FRED ALGER MANAGEMENT, LLC 2.77%
5State Street 2.59%
6MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.39%
7GEODE CAPITAL MANAGEMENT, LLC 1.93%
8BlackRock 1.79%
9GENEVA CAPITAL MANAGEMENT LLC 1.58%
10Voya 1.53%

Reported BioLife Solutions, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BioLife Solutions, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock6,101,765 13.23%Form 13F, quarter ended March 31, 2026
Casdin Capital, LLC4,757,165 10.32%Schedule 13G, filed June 4, 2026
T. Rowe Price Investment Management, Inc.3,665,965 7.95%Schedule 13G, filed September 8, 2026
Vanguard Group3,087,386 6.70%Form 13F, quarter ended March 31, 2026
Integrated Core Strategies (US) LLC2,404,862 5.22%Proxy statement (DEF 14A), proxy filed July 8, 2025
Invesco2,348,532 5.09%Form 13F, quarter ended March 31, 2026
State Street1,577,076 3.42%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)1,470,252 3.19%Form 13F, quarter ended March 31, 2026
Dimensional Fund Advisors1,035,757 2.25%Form 13F, quarter ended March 31, 2026
Geode Capital971,927 2.11%Form 13F, quarter ended March 31, 2026

Percentages above are of 46,104,888 shares outstanding, as reported by BioLife Solutions, Inc. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BioLife Solutions, Inc.'s shareholder meeting held August 20, 2025, in the 2025-2026 proxy season, 261 asset managers reported votes on at least one of its 9 ballot items in their SEC Form N-PX filings, covering 2,512 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — BioLife Solutions, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BioLife Solutions, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 21, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BioLife Solutions, Inc.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BioLife Solutions, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “BioLife Solutions, Inc. 2025 Annual Meeting (2025-2026 season)”, https://proxyvotesnow.com/company/biolife-solutions-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.